Please assess the completion status of the following clinical trial:

Trial Title: Intravenous Lidocaine in the Prevention of Postoperative Vomiting in Elective Tonsil Surgery

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: TRIPLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Children between 2 and 12 years~* ASA I or II~* Programmed for elective tonsillectomy with or without adenoidectomy under general anesthesia~Exclusion Criteria:~* Obesity, defined as body mass index (BMI) ≥ 95th percentile for age and sex.~* Use of antiemetic drugs during the 24 hours before surgery.~* Gastroesophageal reflux.~* History of allergy to any of the drugs used in the study.~* Down Syndrome.

- Gender: ALL
- Minimum Age: 2 Years
- Maximum Age: 12 Years
- Healthy Volunteers: f

Study Arms:
- Group L (Type: ACTIVE_COMPARATOR): Group L Lidocaine load dose 1.5 mg / kg over 5 minutes, followed by continuous infusion of 2 mg / kg / h, which is maintained until the end of surgical procedure
- Group P (Type: PLACEBO_COMPARATOR): Normal saline solution administered under the same regimen

Based on this trial design, predict the completion outcome and termination type (if applicable).